Μετάβαση στο περιεχόμενο

Ετικέταamyotrophic lateral sclerosis

With a Strong Focus on ALS Patients, Mitsubishi Tanabe Pharma America Works to Increase Access and Foster Development

It has been one year since Mitsubishi Tanabe Pharma America’s (MTPA) Radicava was approved as the first treatment for amyotrophic lateral sclerosis (ALS) in more than 20 years. Since its approval, … Continue Reading With a Strong Focus on ALS Patients, Mitsubishi Tanabe Pharma America Works to Increase Access and Foster Development